Humacyte Stock

humacyte.comHealthcareFounded: 2004Funding to Date: $440MM

Humacyte is the developer of a biotechnology platform designed to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine.

Register for Details

For more details on financing and valuation for Humacyte, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Humacyte.

Register Today

Team

Management Team

Theodore Lithgow Ph.D
Chief Operating Officer
William Tente
Chief Regulatory Officer
Shannon Dahl Ph.D
Co-Founder
Jeffrey Lawson MD
President & Chief Executive Officer
Carrie Cox
Chairman & Chief Executive Officer
Laura Niklason MD
Co-Founder & Board Member
Jack Harvey
Vice President, Bioprocessing
Douglas Blankenship
Chief Financial Officer
Juliana Blum Ph.D
Co-Founder & Vice President, Business Operations & Tissue Services
Heather Prichard Ph.D
Senior Vice President of Product Development

Board Members

Brady Dougan
Credit Suisse
Laura Niklason MD
Carrie Cox
Max Wallace JD
Dale Sander
Kathleen Sebelius
Robert Anderson MD
Robert Langer Ph.D

Other companies like Humacyte in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM